Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Targeted Oncology
JournalCitation impact & published research
Targeted Oncology is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,231 works, 27,143 citations, an h-index of 73 and an APC (USD) of 4,390.
1,231
Works
27,143
Citations
73
h-index
4,390
APC (USD)
IDs:OpenAlex
What are the most-cited papers on Targeted Oncology?
ScholarIQmost cited works
Renal Toxicities of Targeted Therapies
Anum Abbas, Mohsin Mirza, Apar Kishor Ganti, Ketki Tendulkar
Targeted Oncology. 201592 Citations
Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management
Caroline Prieux‐Klotz, Marie Dior, Diane Damotte, Johann Dréanic, Bertrand Brieau, Catherine Brézault, Véred Abitbol, Stanislas Chaussade, Romain Coriat
Targeted Oncology. 201776 Citations
Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma
Laura Alwan, Kenneth F. Grossmann, Daniel S. Sageser, Joan Van Atta, Neeraj Agarwal, Jeffrey A. Gilreath
Targeted Oncology. 201356 Citations
TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting
Lyudmila Bazhenova, Andrew Lokker, Jeremy Snider, Emily Castellanos, Virginia Fisher, Marc Fellous, Shivani Nanda, Jihong Zong, Karen Keating, Xiaolong Jiao
Targeted Oncology. 202145 CitationsOPEN ACCESS
Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib
Yuxin Mu, Xuezhi Hao, Ke Yang, Di Ma, Shouzheng Wang, Ziyi Xu, Junling Li, Puyuan Xing
Targeted Oncology. 201940 CitationsOPEN ACCESS
Related on ScholarIQ
Renal Toxicities of Targeted Therapies
Paper
Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management
Paper
Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma
Paper
TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting
Paper
Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib
Paper
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo
Paper